$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$702.87M
Market Cap
-
P/E Ratio
-2.5
EPS
$10.38
52 Week High
$1.45
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Lexeo Therapeutics, Inc. is a New York-based clinical-stage genetic medicine company dedicated to developing pioneering therapies for hereditary and acquired diseases. Leveraging advanced gene-editing technologies, Lexeo is advancing a robust and diverse pipeline of innovative treatments aimed at addressing significant unmet medical needs and enhancing patient outcomes. With a strong commitment to proprietary platform development, Lexeo is well-positioned to make a substantial impact in the burgeoning field of genetic medicine, representing a compelling opportunity for institutional investors interested in transformative healthcare solutions.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
DNN
IBRX
RIOT
WBD
APLD
AG
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
DNN
IBRX
RIOT
WBD
APLD
AG
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL